CA125 is a tumor marker indicator whose elevation may be associated with diseases such as pelvic inflammatory disease, endometriosis, fallopian tube cancer, and ovarian cancer.
CA125 is a glycoprotein originating from embryonic somatic epithelial tissue and was first discovered as a tumor marker for epithelial ovarian cancer, and is also a tumor marker commonly used today.
In general, tumors arising from organs that develop from embryonic epithelium, such as fallopian tube, ovarian, mesothelial cell, and ovarian epithelial cancers, generally result in an increase in CA125.
However, it should be noted that a high CA125 alone cannot be diagnosed as a malignant tumor, especially for pelvic inflammatory disease, endometriosis, pregnancy, and other diseases that are often accompanied by elevated CA125.
Therefore, if women find high CA125 and other normal tumors, it is recommended that they should consult a doctor in time, complete the relevant examinations, clarify the cause of the disease under the guidance of the doctor, and target the treatment to avoid delaying the condition.